Viewing Study NCT06938659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-01-13 @ 3:48 AM
Study NCT ID: NCT06938659
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-22
First Post: 2025-03-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
Sponsor: Dhaka Medical College
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Low dose Factor VIII View
None Low dose Emicizumab View
None Prophylaxis View
None Hemophilia A with inhibitor View